Ftse Mib
38.348,16
-0,53%
DAX
22.433,63
-1,88%
S&P 500
6.144,15
0,24%
NASDAQ
20.056,25
0,07%
Bitcoin
97.084,23
0,47%
Pepperstone
Advertisement
Registration Strip Icon for alerts Registrati per avvisi in tempo reale, portafoglio personalizzato e movimenti di mercato.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Corvus Pharmaceuticals Inc (CRVS) Corvus Pharmaceuticals Inc (CRVS) Notizie

Corvus Pharmaceuticals Inc

CRVS
4,56
-0,21 (-4,40%)
20 Feb 2025 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
04/2/202514:00GLOBECorvus Pharmaceuticals to Present at the Oppenheimer 35th..
13/1/202513:30EDGAR2Form 8-K - Current report
13/1/202513:30GLOBECorvus Pharmaceuticals Announces Data from Cohort 2 of..
07/1/202522:01GLOBECorvus Pharmaceuticals to Present at the 43rd Annual J.P...
23/12/202422:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/12/202422:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/12/202413:30EDGAR2Form 8-K - Current report
18/12/202413:30GLOBECorvus Pharmaceuticals Announces Interim Data from..
17/12/202422:01GLOBECorvus Pharmaceuticals to Announce Interim Data from..
04/12/202422:05GLOBECorvus Pharmaceuticals Announces Publication of Biochemistry..
14/11/202416:01GLOBECorvus Pharmaceuticals Announces New Preclinical Data..
12/11/202422:03EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
12/11/202422:02EDGAR2Form 8-K - Current report
12/11/202422:01GLOBECorvus Pharmaceuticals Provides Business Update and Reports..
09/11/202419:40GLOBECorvus Pharmaceuticals Announces New Data Highlighting..
05/11/202422:02GLOBECorvus Pharmaceuticals to Provide Business Update and Third..
23/10/202422:11EDGAR2Form 8-K - Current report
10/9/202414:30GLOBECorvus Pharmaceuticals Initiates Registrational Phase 3..
03/9/202422:05GLOBECorvus Pharmaceuticals to Present at the H.C. Wainwright..
16/8/202406:15EDGAR2Form EFFECT - Notice of Effectiveness
06/8/202423:31EDGAR2Form S-3 - Registration statement under Securities Act of..
06/8/202422:02EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
06/8/202422:01EDGAR2Form 8-K - Current report
06/8/202422:01GLOBECorvus Pharmaceuticals Provides Business Update and Reports..
01/8/202414:30GLOBECorvus Pharmaceuticals Granted FDA Fast Track Designation..
31/7/202414:30GLOBECorvus Pharmaceuticals to Provide Business Update and Second..
25/7/202414:30GLOBEPublication of Preclinical Data in Science Signaling..
17/6/202422:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/6/202422:15EDGAR2Form 8-K - Current report
30/5/202422:02GLOBECorvus Pharmaceuticals to Present at the Jefferies Global..
07/5/202423:19EDGAR2Form S-8 - Securities to be offered to employees in employee..
07/5/202423:16EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/5/202423:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/5/202422:11EDGAR2Form 8-K - Current report
06/5/202422:01EDGAR2Form 8-K - Current report
06/5/202422:01GLOBECorvus Pharmaceuticals Provides Business Update and Reports..
02/5/202422:02GLOBECorvus Pharmaceuticals to Provide Business Update and First..
02/5/202414:30GLOBECorvus Pharmaceuticals Announces Pricing of $30.6 Million..
09/4/202422:01GLOBECorvus Pharmaceuticals Announces Initiation of..
19/3/202421:02GLOBECorvus Pharmaceuticals Provides Business Update and Reports..
19/3/202412:27IHMARKETNEWSUS Index Futures Decline Ahead of Federal Reserve Meeting,..
13/3/202421:02GLOBECorvus Pharmaceuticals to Provide Business Update and Fourth..
01/3/202423:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
Apertura: 4,71 Min: 4,51 Max: 4,76
Chiusura: 4,77

La tua Cronologia

NASDAQ
CRVS
Corvus Pharmaceuticals
TSX
EINC
E Automotive
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network

Rimuovi gli annunci

Iscriviti per un'esperienza senza pubblicità

Nessuna pubblicità

Prova adesso

Conserva gli annunci